Holen Sie sich die Stockscreener-App
11.10
1.93%
0.21
Schlusskurs vom Vortag:
$10.89
Offen:
$10.92
24-Stunden-Volumen:
439.42K
Relative Volume:
0.66
Marktkapitalisierung:
$449.17M
Einnahmen:
$324.01M
Nettoeinkommen (Verlust:
$-192.37M
KGV:
-2.3222
EPS:
-4.78
Netto-Cashflow:
$-23.46M
1W Leistung:
-10.91%
1M Leistung:
+19.74%
6M Leistung:
+43.97%
1J Leistung:
+86.87%
1-Tages-Spanne:
$10.82
$11.21
1-Wochen-Bereich:
$10.77
$12.59
52-Wochen-Spanne:
$5.26
$13.50
Angiodynamic Inc Stock (ANGO) Company Profile
Firmenname
Angiodynamic Inc
Sektor
Telefon
(518) 798-1215
Adresse
14 PLAZA DRIVE, LATHAM
Vergleichen Sie ANGO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
11.10 | 449.17M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
588.50 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.21 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.65 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.18 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
330.47 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-17 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | Herabstufung | Craig Hallum | Buy → Hold |
| 2017-04-07 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-03-30 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | Eingeleitet | Barclays | Equal Weight |
| 2016-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-04-08 | Fortgesetzt | Piper Jaffray | Neutral |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-11-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | Bestätigt | Canaccord Genuity | Hold |
| 2012-06-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | Hochstufung | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | Herabstufung | Wedbush | Neutral → Underperform |
| 2010-09-08 | Bestätigt | Wedbush | Neutral |
Alle ansehen
Angiodynamic Inc Aktie (ANGO) Neueste Nachrichten
BlackRock, Inc. Reduces Stake in AngioDynamics Inc - GuruFocus.com
Market Insight: Angiodynamic Inc (ANGO)’s Notable Drop, Closing at 11.04 - The Dwinnex
Angiodynamic Inc (ANGO) receives an Outperform rating from Oppenheimer - Knox Daily
Is it a good time to sell Palantir Technologies Inc [PLTR] shares after an insider sold 4,000 shares? - Knox Daily
Investing in CRH Plc (CRH): What You Must Know - Knox Daily
AngioDynamics Inc. (NASDAQ: ANGO) Reports Narrowed Net Loss and 8% Revenue Decline in Q2 FY2025 - HPBL
AngioDynamics, Inc.'s (NASDAQ:ANGO) Share Price Boosted 38% But Its Business Prospects Need A Lift Too - Simply Wall St
With 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns - Yahoo Finance
Assenagon Asset Management S.A. Reduces Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Stock Position Raised by JPMorgan Chase & Co. - Defense World
Barclays PLC Boosts Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
**AngioDynamics (NASDAQ:ANGO) Reports Fiscal Second Quarter Results** - Defense World
AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines - Yahoo Finance
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2025 Earnings Call Transcript - Insider Monkey
AngioDynamics Reports Growth and Advances NanoKnife System - Yahoo Finance
Institutional investors are AngioDynamics, Inc.'s (NASDAQ:ANGO) biggest bettors and were rewarded after last week's US$154m market cap gain - Simply Wall St
AngioDynamics (NASDAQ:ANGO) Reaches New 52-Week High After Better-Than-Expected Earnings - Defense World
AngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
AngioDynamics, Inc. Reports Growth in Med Tech Segment - TipRanks
AngioDynamics Inc Reports Q2 Revenue of $73 Million, Exceeding E - GuruFocus.com
AngioDynamics: A Surgical Approach To Market Growth (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Hits New 52-Week High Following Strong Earnings Report – Market - HPBL
AngioDynamics hopes NanoKnife will become go-to prostate cancer treatment - Times Union
AngioDynamics Inc. (ANGO) reports earnings - Quartz
AngioDynamics: Fiscal Q2 Earnings Snapshot - The Washington Post
AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday - Benzinga
AngioDynamics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 - Marketscreener.com
AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8% - AlphaStreet
What To Expect From AngioDynamics Inc (ANGO) Q2 2025 Earnings - GuruFocus.com
AngioDynamics to Showcase Revolutionary NanoKnife Cancer Treatment System at Investor Event - StockTitan
Geode Capital Management LLC Boosts Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Barclays PLC Has $651,000 Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics (NASDAQ:ANGO) vs. Orthofix Medical (NASDAQ:OFIX) Head-To-Head Contrast - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Shares Sold by Franklin Resources Inc. - Defense World
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Declines By 12.3% - MarketBeat
State Street Corp Has $6.31 Million Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Stake Raised by Fmr LLC - Defense World
AngioDynamics Sets Date for Q2 Earnings, Unveils Special NanoKnife Investor Event - StockTitan
XTX Topco Ltd Takes $582,000 Position in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
In-Depth Examination Of 4 Analyst Recommendations For AngioDynamics - Benzinga
There Is A Reason AngioDynamics, Inc.'s (NASDAQ:ANGO) Price Is Undemanding - Simply Wall St
AngioDynamics, Inc. (NASDAQ:ANGO) Stock Position Increased by BNP Paribas Financial Markets - MarketBeat
FDA clears AngioDynamics’ NanoKnife pulsed field ablation system for prostate cancer - Fierce Biotech
AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife - Marketscreener.com
AngioDynamics Secures FDA Clearance for Breakthrough Prostate Cancer Treatment System After Strong Trial Results - StockTitan
Jacobs Levy Equity Management Inc. Sells 95,157 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
AngioDynamics Port Defect Caused Infection, Ga. Man Says - Law360
Systematic Financial Management LP Has $18.75 Million Stake in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
Finanzdaten der Angiodynamic Inc-Aktie (ANGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
10.10%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):